{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:48:30Z","timestamp":1782373710864,"version":"3.54.5"},"reference-count":0,"publisher":"AME Publishing Company","issue":"3","content-domain":{"domain":["amegroups.com"],"crossmark-restriction":false},"short-container-title":["Chin Clin Oncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.21037\/cco-2025-1-183","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:14:45Z","timestamp":1782371685000},"page":"51-51","update-policy":"https:\/\/doi.org\/10.21037\/ame_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Age, endocrine therapy persistence, and recurrence risk in hormone receptor-positive early breast cancer: clarifying a long-standing clinical question"],"prefix":"10.21037","volume":"15","author":[{"given":"Marcus","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8611","published-online":{"date-parts":[[2026,6]]},"container-title":["Chinese Clinical Oncology"],"original-title":[],"link":[{"URL":"https:\/\/cco.amegroups.com\/article\/download\/155710\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:14:50Z","timestamp":1782371690000},"score":1,"resource":{"primary":{"URL":"https:\/\/cco.amegroups.com\/article\/view\/155710\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":0,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]},"published-print":{"date-parts":[[2026,6]]}},"URL":"https:\/\/doi.org\/10.21037\/cco-2025-1-183","relation":{},"ISSN":["2304-3865","2304-3873"],"issn-type":[{"value":"2304-3865","type":"print"},{"value":"2304-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}